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Abstract
Retinoic acid (RA), a metabolite of vitamin A, has many physiological functions, and mounting evidence points
to important roles in cognition. In vitro experiments indicate that RA is involved in homeostatic synaptic scal-
ing in the hippocampus, which supports overall network stability during learning. It has been previously deter-
mined that disrupted RA signaling in the hippocampus causes deterioration of memory, that RA signaling
declines with age in brain, and that application of RA reverses this decline. Here, we explore whether RA sig-
naling is altered in an animal model of neurocognitive aging. We used a Morris water maze protocol to study
cognitive decline in aged rats, which assesses hippocampus-dependent spatial memory and reveals substan-
tial interindividual differences in aged animals. Aged unimpaired (AU) rats perform on par with young (Y), while
aged impaired (AI) animals exhibit spatial memory deficits. We show that the major substrate for RA, retinol
binding protein 4 (RBP4), is decreased in AU rats, and retinol cell surface receptor declines with chronological
age. Other affected components of RA signaling include selective increases in AI animals in hippocampal syn-
thesis (RALDH1) and catabolism of RA (CYP26B1), RA receptor a, the RA regulated ionotropic glutamate re-
ceptor (GluR1), as well as fragile X mental retardation protein (FMRP). The results support the conclusion that,
surprisingly, increased RA signaling in the aged hippocampus is associated with poor cognitive outcome.
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Significance Statement
Growing evidence indicates that retinoic acid (RA) function extends well beyond metabolic control and in-
cludes the regulation of memory-related synaptic plasticity. Here, we explore whether RA signaling is al-
tered in an animal model of neurocognitive aging. We show that in fact RA function is altered at nearly all
levels examined, and these results are unrelated to metabolic aging. Overall, the net effect points in the di-
rection of increased RA signaling in impaired aged animals, which may contribute to disruption in excita-
tion/inhibition balance, a prominent feature of age-related cognitive impairment and suspected early event
in the pathogenesis of Alzheimer’s disease.
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Introduction
Circulating levels of retinoic acid (RA), a metabolite of
vitamin A (retinol), are dependent on dietary availability
because animals are unable to synthesize retinol de novo.
Dietary sources can be from plants in the form of carote-
noids or animal sources (retinyl esters; Blomhoff and
Blomhoff, 2006). RA has many physiological functions,
including control of neuronal differentiation during devel-
opment, and modulation of neuronal plasticity and neuro-
genesis in the adult hippocampus (Maden, 2007; Nomoto
et al., 2012; Chen et al., 2014). A potential role in memory
processes is emerging and RA supplementation as a po-
tential intervention for successful cognitive aging has re-
ceived preliminary support (Mingaud et al., 2008; Dumetz
et al., 2020). Complementing these findings, retinol defi-
ciency during adolescence causes memory impairments
comparable to those seen in aged rodents, and vitamin A
supplementation can reverse these deficits (Etchamendy
et al., 2001; Bonnet et al., 2008). The age-related reduc-
tion of plasma retinol binding protein (RBP; Kocełak et al.,
2018), and retinol (Van Der Loo et al., 2004), as well as de-
creased vitamin A metabolism (Touyarot et al., 2013), sug-
gest an overall decrease in RA signaling in aging (Enderlin
et al., 1997; Etchamendy et al., 2003; Das et al., 2014). A
global diminishment in RA functions may link metabolic
aging and neurobiological mechanisms responsible for
age-associated cognitive decline.
In the blood, retinol circulates freely or bound to RBP4,
which is carried by transthyretin (TTR). TTR allows stable
transport of RBP4 bound retinol and prevents RBP4 filtra-
tion and degradation by the kidney (Kanai et al., 1968;
Palha, 2002; Vieira and Saraiva, 2014). Circulating retinol
enters the cell via stimulated by RA-6 (STRA6) receptor
or, because of its lipophilic properties, via cell membrane
diffusion (Napoli, 2012; O’Byrne and Blaner, 2013). Inside
the cell, retinol binds to the cellular RBPs and is further
metabolized to RA. The last step of RA synthesis is cata-
lyzed by the retinaldehyde dehydrogenase enzymes
(RALDHs). RA can exhibit genomic or non-genomic func-
tions, via binding to RA receptors (RARs and RXRs), dif-
fuse to neighboring cells, or be catabolized by the
cytochrome p450 family enzymes (CYP26s; Chen and
Napoli, 2008; Chen et al., 2008; Shearer et al., 2012).
The growth, development, and ability of neurons to adapt
to a changing environment are crucial for normal cognition.
Mounting evidence points to the involvement of RA in mem-
ory formation. RA is involved in homeostatic synaptic
scaling in the hippocampus, which maintains neuronal net-
work stability in the face of learning-induced changes in
synaptic strength (Groth and Tsien, 2008). This modulation
is mediated through RA binding to its receptor a (RARa),
which acts as an RNA-binding granule (Maghsoodi et al.,
2008), promoting the dissociation of ionotropic glutamate
receptor (GluR1) mRNA bound to RARa, making it available
for translation. The fragile X mental retardation protein
(FMRP) is required for the translation of GluR1, which re-
sults in an increase of dendritic synthesis of GluR1 and syn-
aptic strength (Aoto et al., 2008; Soden and Chen, 2010).
The expression of glutamate receptors and glutamate up-
take decline with age, potentially contributing to memory
decline (Segovia et al., 2001; Yang et al., 2015).
To examine the link between hippocampal RA signaling
and neurocognitive aging, we used a well-established ani-
mal model of age-related cognitive decline. In this model,
the hippocampus in aged rats with spatial memory defi-
cits displays a complex constellation of changes relative
to younger animals and age-matched subjects with intact
memory, including a decrease in the number of inhibitory
somatostatin neurons in the dentate gyrus, increased
basal Arc protein expression but diminished behavioral in-
duction in the pyramidal cell fields, as well as pyramidal
neuron hyperactivity in the CA3 region (Wilson et al.,
2005; Spiegel et al., 2013; Fletcher et al., 2014). Here, we
measured plasma RBP4 and protein levels of hippocam-
pal STRA6 receptor, RA synthesizing and catabolizing en-
zymes, RARa, FMRP, and GluR1 in young (Y) rats and
aged animals with and without memory impairment.
Materials and Methods
Animals
Y (sixmonths; n=16) and aged (24months; n=32) male
Long–Evans rats (Charles River Laboratories) were single
housed in a climate-controlled vivarium, on a 12/12 h
light/dark cycle. Animals had ad libitum access to food
(Teklad Global 18% protein extruded rodent diet with vita-
min A acetate, 30 IU/g, 1 IU= 0.3 mg retinol) and water.
Rats were screened for health conditions, including skin
conditions incompatible with water maze exposure, cata-
racts and tumors. Only healthy animals were used.
Ethical statement
This study was conducted in accordance with the rec-
ommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
The protocol was approved by the Animal Care and Use
Committee of the National Institute on Aging (ASP number
LBN-407-2020).
Spatial learning andmemory/background behavioral
characterization
Hippocampal-dependent spatial learning and memory
were assessed using a Morris water maze protocol,
optimized for documenting individual differences in
aging (Gallagher et al., 1993). Briefly, animals were
trained to find the location of a hidden platform, three
trials per day over eight consecutive days. Probe trials
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were interpolated throughout training (one the last trial
of every other day), to record spatial bias for the loca-
tion of the platform. For the probes, the platform was
unavailable for escape during the first 30 s of the trial.
A learning index (LI) score for each animal was calcu-
lated based on average proximity (in centimeters) to
the hidden escape location across the last three probe
trials. Lower LI scores indicate better search accuracy
focused on the escape location. Aged animals that
performed on par with Y were classified as aged unim-
paired (AU), while aged animals that performed above
an LI cutoff based on Y were classified as aged im-
paired (AI). The cut off (LI of 240) is based on the nor-
mative distribution of scores for many hundreds of Y
rats in previous research (Gallagher et al., 1993; Rapp
and Gallagher, 1996; Maei et al., 2009; Haberman et
al., 2012; Tomás Pereira and Burwell, 2015).
Tissue collection
Euthanasia for postmortem analysis occurred in the
morning/early afternoon no sooner than twoweeks
after completing water maze training, to minimize the
influence of behavioral testing on the RA measures of
interest. Animals were disoriented or briefly anaesthe-
tized using Isoflurane and decapitated. Trunk blood
was collected in heparinized tubes, which were slowly
inverted multiple times and placed on wet ice. Blood
was transferred to Eppendorf tubes and spun at 1500
G for 20min at 4°C. Supernatant (plasma) was then
transferred to a separate tube and both were kept at
80°C. Brains were extracted, and hippocampi were
rapidly dissected over ice, snap frozen on dry ice, and
stored at 80°C until required.
ELISA
RBP4 ELISA was performed using a rat RBP4 kit (Abcam,
ab203362). Plasma samples were diluted to 1:500,000, be-
fore performing the assay. A standard curve was created
using stock RBP supplied and results were obtained by
measuring the absorption at 450nm.
Plasma glucose, triglyceride, and creatinine assays
Plasma glucose levels were measured with an assay kit
(Abcam, ab65333). Plasma samples were first deprotei-
nized with 10-kDa spin columns (Abcam, ab93349). A
standard curve was generated using stock glucose pro-
vided. The assay was run per manufacturer instructions
and the absorption was measured at 570nm. Triglyceride
content was tested using an assay kit (Biovision, #622).
Manufacturer’s instructions were followed to obtain the
standard curve from the triglyceride stock provided, the
results were obtained by measuring the absorption at
570nm, and plasma triglyceride content was calculated.
An assay kit was used to determine plasma creatinine
content (Biovision, #625). Deproteinized plasma samples
were tested. Manufacturer instructions were followed,
and stock creatinine was used to create a standard curve
and absorption was read at 570nm.
Protein extraction and quantification
Proteins from one hippocampus per animal (Y n=16, aged
n=32) were extracted using tissue protein extraction reagent
(T-PER; Thermo Fisher Scientific) with HALT protease inhibi-
tor cocktail (100; Thermo Fisher Scientific), homogenized,
sonicated, spun down for 20min (13,200 rpm at 4°C) and su-
pernatant collected. Protein content in the supernatant was
measured using Pierce’s bicinchoninic acid (BCA) assay
(Thermo Fisher Scientific). Proteins were made into stock so-
lution of 5mg/ml.
Synaptosome preparation
Synaptic protein extraction reagent (Syn-PER; Thermo
Fisher Scientific) was used to isolate synaptosomes,
which contain key presynaptic and postsynaptic proteins.
Briefly, 10 ml of Syn-PER was added to each milligram of
hippocampal tissue, which was then homogenized using
Dounce homogenizer. Samples were then centrifuged at
3600 rpm for 10min at 4°C. Supernatant was placed in a
fresh tube and centrifuged again at 12 700 rpm for 20min
at 4°C. Supernatant was then removed, and the pellet re-
suspended in Syn-PER (2 ml/g of tissue). Again, protein
content was measured by BCA assay and made into
5mg/ml stock solution.
Western blotting
Samples (25mg of protein per well/lane) were sepa-
rated by SDS-PAGE Bis-Tris gel (Invitrogen) and MES-
SDS buffer (Invitrogen). All groups (Y, AU, and AI) were
represented within each gel. Following separation, pro-
teins were transferred onto PVDF membranes (Invitrogen)
using an iBlot dry blotting system (Invitrogen). The anti-
bodies were diluted in blocking solution (2% ELC advance
blocking agent; GE Healthcare) in wash buffer (TBS and
0.1% Tween 20) and membranes were incubated overnight
at 4°C. Immunoreactivity was detected by application of con-
jugated secondary antibodies (Alexa Fluor 488; Alexa Fluor
546; CY5; Jackson ImmunoResearch). The immunoblots
were scanned on a Sapphire imager (Azure Biosystems) at
100-mm resolution and quantified using ImageJ software
(National Institutes of Health). Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) or b -actin were used as loading
controls and all results were normalized to the expression of
these proteins.
Primary antibodies
The primary antibodies and their dilutions are listed in
Table 1.
Statistical analysis
Statistical analysis was performed using Prism 7.0
(GraphPad Software). Unless otherwise stated, unpaired
two-tailed Student’s t test was used when comparing two
groups, while two-way ANOVA with Tukey’s multiple
comparison test was applied to multiple group analysis.
Pearson r correlation coefficients were calculated to in-
vestigate associations between variables of interest.
Values of p, 0.05 were considered statistically signifi-
cant. An observation was considered an outlier if its value
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was.2 SDs from themean. This was the case for only one Y
animal, which was excluded from the RALDH1 analysis.
Results
Aged rats display increased individual differences in
spatial memory
Spatial memory was assessed in the Morris water maze
using a protocol optimized for the study of cognitive aging
(Gallagher et al., 1993). Over the course of testing rats were
given probe trials to assess spatial bias for the platform loca-
tion, and LI scores were calculated for each animal. As pre-
dicted, aged animals, on average displayed higher LI scores
[Y mean=182.3 (n=16), aged mean=239.1 (n=32), t(46) =
4.537, p, 0.0001; Fig. 1A]. Consistent with many earlier
studies (Lee et al., 2005; Castellano et al., 2012; Fletcher et
al., 2014; Myrum et al., 2019), the aged group exhibited sub-
stantially increased variability such that some rats performed
on par with Y, while others performed well outside the normal
range. Aged animals with LI scores below 240 (n=15) were
classified as AU, and rats that scored above 240 (n=17) were
operationally defined AI. This animal model provides an op-
portunity to test for chronological age effects (Y vs aged),
while also allowing the study of mechanisms of cognitive
aging, by comparing the Y, AU, and AI, and exploring poten-
tial linear correlations between LI scores and RA signaling
factors in the same subjects.
Plasma RBP4 is reduced in aged animals without
memory impairment
Retinol can circulate free in blood or bound to RBP4/
TTR complex. We tested plasma RBP4 concentration,
Figure 1. Spatial memory performance, animal weight, and plasma RBP4 levels. LI scores for individual Y and aged animals (A);
plasma RBP4 levels presented as % of Y baseline (B, C); correlation of plasma RBP4 and LI score (D); mean body weights of ani-
mals tested. Note that body weight did not differ among the aged rats (E, F); correlation of plasma RBP4 and body weight (G).
Results shown as bars with individual animal data plotted. Statistical analysis, unpaired two-tailed Student’s t test (B, E, F), one-
way ANOVA, with Tukey’s multiple comparisons test (C), and linear regression (D, G; all animals, gray line; aged animals, black line);
**p, 0.01, ***p, 0.001. Y n=16 and aged n=32 (AU n=15, AI n=17; panel A); Y n=8 and aged n=16 (AU n=8, AI n=8; panels
B–G). Error bars represent SEM.
Table 1: Primary antibodies used for the Western blotting (WB) with corresponding dilutions
Antibody name Host WB dilution Predicted molecular weight Supplier Catalog number
Anti-RALDH1 Goat 1:3000 55 kDa Abcam ab9883
Anti-RALDH3 Rabbit 1:1000 57 kDa Abcam ab129815
Anti-b -actin Mouse 1:30,000 45 kDa BioVision Incorporated 3598
Anti-CYP26A1 Mouse 1:1000 49 kDa Santa Cruz Biotechnology sc-53618
Anti-CYP26B1 Rabbit 1:1000 58–60 kDa ProteinTech Antibodies 21555-1-AP
Anti-FMRP Rabbit 1:1000 80 kDa Abcam ab17722
Anti-GAPDH Rabbit 1:10,000 37 kDa Santa Cruz Biotechnology sc-25778
Anti-GluR1 Rabbit 1:500
1:250 (s)
106 kDa ThermoFisher Scientific PA1-46151
Anti-PSD95 Rabbit 1:500 95 kDa Millipore AB9708
Anti-RARa Goat 1:2000
1:1000 (s)
51 kDa Abcam ab28767
Anti-Stra6 Rabbit 1:1000 95 kDa ProteinTech Antibodies 22001-1-AP
(s), synaptosome preparation
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which is indicative of retinol availability. We found no dif-
ferences in plasma RBP4 between the Y and aged groups
(t(22) = 1.568, p=0.131; Fig. 1B). However, RBP4 levels
were significantly lower in AU compared with Y and AI
rats (F(2,21) = 11.48, p=0.0004; Y vs AU p=0.0019; AU vs
AI p=0.0009; Fig. 1C). Additionally, levels of circulating
RBP strongly correlated with spatial memory performance
among the aged rats such that subjects with higher RBP4
levels displayed worse spatial memory (n=16, r2 = 0.303,
p=0.027; Fig. 1D, black line). The correlation was not sig-
nificant when the data for Y rats were included in the anal-
ysis (n=24, r2 = 0.055, p=0.273; Fig. 1D, gray line),
suggesting that coupling between RBP4 availability and
hippocampal memory function emerges specifically in re-
lation to cognitive aging.
Although the liver is the major peripheral source of RBP4,
it is also released by adipocytes (Thompson et al., 2017), and
elevated RBP4 levels have been reported in obese and dia-
betic individuals (Yang et al., 2005; Esteve et al., 2009). Since
aged rats are heavier than Y adults (Y mean=653 g, aged
mean=828 g, t(22) = 3.979, p=0.0006; Fig. 1E) we examined
whether RBP4 levels correlate with body weight. In the aged
group there was no difference in body weight between AU
and AI rats (t(14) = 0.06, p=0.95; Fig. 1F). RBP4 levels were
unrelated to body weight in Y and aged animals considered
together (n=24, r2 = 0.01, p=0.65; Fig. 1G, gray line), and no
correlation between body weight and RBP levels was de-
tected when AU and AI rats were considered alone (n=16, r2
= 0.032, p=0.032; Fig. 1G, black line). These results indicate
that RBP4 levels in aging are more tightly linked with individu-
al differences in cognitive outcome than with the effects of
chronological age, per se.
Aged Long–Evans rats do not display metabolic
syndrome
Plasma glucose, triglyceride and creatinine content
were measured to determine whether aged animals dis-
play metabolic symptoms that might affect RBP4 levels.
Plasma glucose was significantly lower in aged animals
compared with Y (t(22) = 2.445, p=0.023; Fig. 2A). This dif-
ference was especially prominent when AI rats were com-
pared with Y (F(2,21) = 4.155, p=0.03; Y vs AI, p=0.023;
Fig. 2B), but not with AU (p=0.34). Thus, despite substan-
tially increased weight, pancreatic function seems to keep
glucose levels on par with, or lower than, in Y rats com-
pared with AU and AI animals. Plasma triglyceride content
was measured to test liver function, and the results
showed no difference between Y and aged animals (t(22) =
0.319, p=0.75; Fig. 2C), or when aged rats were split de-
pending on their cognitive profile (F(2,21) = 0.454, p=0.64;
Fig. 2D). Kidney function was assessed indirectly via plas-
ma creatinine levels. Subjects with chronic kidney disease
often display increased circulating RBP4 (Kocełak et al.,
2018; Xun et al., 2018). We saw no differences in plasma
creatinine levels between Y and aged rats (t(22) = 1.133,
p=0.27; Fig. 2E). However, we found significantly lower
plasma creatinine in AI group compared with Y and AU
rats (F(2,21) = 8.59, p=0.002; Y vs AI, p=0.0116; AU vs AI,
p=0.002; Fig. 2F). These data taken together indicate
that the RBP4 results in aged rats are not a secondary
consequence metabolic disease.
Hippocampal STRA6 receptor expression is reduced
in aged animals
STRA6 is a cell surface receptor by which retinol enters
the cell. We measured protein expression of this RA recep-
tor in whole hippocampus from Y and aged animals. Levels
of STRA6 were significantly lower in aged animals compared
with Y (t(22) = 6.00, p,0.0001; Fig. 3B). This was true
for aged rats without and with spatial memory impairment
(F(2,21) = 17.40, p,0.0001; Y vs AU p, 0.0001; Y vs AI,
p=0.0002; Fig. 3C). Moreover, hippocampal STRA6 protein
levels did not differ between the aged subgroups (Fig. 3C) or
correlate with memory performance (Y and aged: n=24, r2 =
0.0.121, p=0.096; aged only: n=16, r2 = 0.010 p=0.148).
These results indicate that, independent of cognitive out-
come, hippocampal aging is associated with a reduction of
the receptor allowing retinol cell entry.
Figure 2. Plasma glucose, triglyceride, and creatinine levels. Levels of plasma glucose (A, B) triglyceride (C, D), and creatinine (E, F)
in the Y, aged, AU, and AI groups. Results shown as bars with individual animal data plotted. Statistical analysis, unpaired two-
tailed Student’s t test (A, C, E), and one-way ANOVA, with Tukey’s multiple comparisons test (B, D, F); *p, 0.05, **p, 0.01. Y n=8
and aged n=16 (AU n=8, AI n=8; all panels). Error bars represent SEM.
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RA synthesis is increased in AI rats
The last step of RA metabolism is catalyzed by the
RALDH enzymes. Here, we assessed the protein expression
of two RALDH enzymes in whole hippocampal preparations,
RALDH1 and RALDH3. Significantly higher levels of RALDH1
protein were found in aged rats relative to Y (t(22) = 2.805,
p=0.011; Fig. 3D). This was the case only for AI, in which hip-
pocampal RALDH1 expression was significantly higher than
in both Y and AU animals (F(2,20) = 9.314, p=0.001; Y vs AI
p=0.001; AU vs AI p=0.026; Fig. 3E). Notably, the expres-
sion of this enzyme correlated with LI scores among the aged
animals such that rats with higher RALDH1 expression
scored more poorly (i.e., higher LI scores; n=16, r2 = 0.42,
p=0.007; Fig. 3F, black line). The correlation was similar
when the Y and aged animals are considered together
(n=23, r2 = 0.518, p=0.0001; Fig. 3F, gray line). RALDH3
protein expression in whole hippocampus was comparable in
the Y and aged groups (t(22) = 1.593, p=0.125; Fig. 3G) and
unrelated to cognitive status (F(2,21) = 1.22, p=0.315; Fig. 3H).
In the aggregate, the results indicate that RALDH1 driven RA
synthesis is potentially increased in the hippocampus of AI
rats.
Figure 3. Protein expression of STRA6, RALDH1, and RALDH3 in the hippocampus. Representative blots for proteins of interest (A),
expression relative to b -actin as a percentage of Y values, L stands for molecular ladder lane. Hippocampal expression of STRA6
(B, C), RALDH1 (D, E), and RALDH3 (G, H). Correlation of protein expression of RALDH1 and LI scores (F). Results shown as bars
with individual animal data plotted. Statistical analysis, unpaired two-tailed Student’s t test (B, D, G), one-way ANOVA, with Tukey’s
multiple comparisons test (C, E, H), and linear regression (F; all animals, gray line; aged animals, black line); *p, 0.05, **p, 0.01,
***p, 0.001, ****p, 0.0001. Y n=8 and aged n=16 (AU n=8, AI n=8; B, G, H); Y n=7 and aged n=16 (AU n=7, AI n=9; D–F).
Error bars represent SEM.
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AI animals display increased RA catabolism
RA is catabolized by the family of cytochrome p450 en-
zymes, CYP26. We measured the protein expression of
CYP26A1 and CYP26B1 enzymes in the whole hippo-
campus preparations. CYP26A1 protein expression was
largely overlapping between Y and aged rats (t(22) = 1.609,
p=0.122; Fig. 4B) without and with spatial memory defi-
cits (F(2,21) = 1.651, p=0.216; Fig. 4C). In contrast, we de-
tected significantly higher CYP26B1 protein expression in
the aged hippocampus (t(22) = 2.428, p=0.024; Fig. 4D).
Interestingly, CYP26B1 levels were selectively increased
in AI, differing from both Y and AU rats (F(2,21) = 10.85,
p=0.0006; Y vs AI p=0.0007; AU vs AI p=0.005; Fig. 4E);
levels in the latter groups were equivalent. Furthermore,
there was a strong correlation between the expression of
CYP26B1 and cognitive performance in the Y and aged
rats (n=24, r2 = 0.455, p=0.0003; Fig. 4F, gray line),
which was also robust among the aged animals alone
(n=16, r2 = 0.265, p=0.040; Fig. 4F, black line), such that
poor spatial memory was coupled with higher CYP26B1
enzyme levels. These results suggest that, although
age-related increases in RA catabolism are selectively ob-
served in aged animals with memory impairment, cata-
bolic enzyme levels are coupled with spatial memory
across the full range of individual differences observed in
both Y and aged rats.
Cellular and synaptosome RARa expression is
increased in AI rats
RARa is one of six RA receptors but the only one that
regulates homeostatic plasticity via non-nuclear action
Figure 4. Protein expression of RA catabolizing enzymes in the hippocampus. Representative blots for proteins of interest (A),
CYP26A1 expression relative to GAPDH, CYP26B1 expression relative to b -actin, L stands for molecular ladder lane. Hippocampal
expression of CYP26A1 (B, C) and CYP26B1 (D, E). Correlation of CYP26B1 levels and LI scores (F). Results shown as bars with in-
dividual animal data plotted. Statistical analysis, unpaired two-tailed Student’s t test (B, D), one-way ANOVA, with Tukey’s multiple
comparisons test (C, E), and linear regression (F; all animals, gray line; aged animals, black line); *p, 0.05, **p, 0.01, ***p, 0.001.
Y n=8 and aged n=16 (AU n=8, AI n=8; B–F). Error bars represent SEM.
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(Aoto et al., 2008; Yang et al., 2015). This receptor is in-
volved in homeostatic synaptic scaling through its inter-
action with FMRP and GluR1. We measured RARa
protein expression in whole hippocampus homogenates
and found no differences in RARa expression between
Y and aged animals (t(22) = 1.321, p=0.2; Fig. 5B).
Interestingly, however, the expression of RARa was sig-
nificantly elevated in AI animals in comparison with both Y
and AU rats (F(2,21) = 6.218, p=0.008; Y vs AI p=0.021,
AU vs AI p=0.013; Fig. 5C). In addition, cognitive scores
correlated with the expression of RARa protein across the
Y and aged rats (n=24, r2 = 0.184, p=0.037; Fig. 5D, gray
line), such that animals with worse spatial memory
showed higher RARa expression. Among the aged ani-
mals alone, water maze performance failed to correlate
significantly with RARa protein expression (n=16, r2 =
Figure 5. Cellular and dendritic RARa expression in the hippocampus. Representative blots for RARa (A), cellular RARa expression
relative to b -actin (bottom two panels), and synaptosome RARa expression relative to PSD95 (top two panes); L stands for molecu-
lar ladder lane. Cytosolic fraction included as a confirmation of the fractionation. Hippocampal expression of RARa (B, C).
Correlation of RARa protein levels with LI scores (D). Synaptosome compartment RARa content (E, F). Correlation of synaptosome
RARa levels and LI scores (G). Results shown as bars with individual animal data plotted. Statistical analysis, unpaired two-tailed
Student’s t test (B, E), one-way ANOVA, with Tukey’s multiple comparisons test (C, F), and linear regression (D, G; all animals, gray
line; aged animals, black line); C, cytosolic fraction; *p, 0.05. Y n=8 and aged n=16 (AU n=8, AI n=8; B–D); Y n=5 and aged
n=15 (AU n=7, AI n=8; E–G). Error bars represent SEM.
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0.155, p=0.131; Fig. 5D, black line). The strength of the
association was nearly identical in both analyses, how-
ever, suggesting that the “aged only” result is less robust
because of the decreased sample size and statistical
power.
Non-genomic actions of RA signaling are mediated by
RA receptors localized outside of the nucleus. We were
specifically interested in the presence of RARa in the syn-
aptosome preparations, because non-nuclear RARa acts
as a mRNA granule containing GluR1 receptor mRNA.
Therefore, we measured RARa protein levels in whole hippo-
campus synaptosome fractions. Similar to results for the
whole cell lysates, we found no differences in RARa protein
presence (t(18) = 1.385, p=0.18; Fig. 5E). However, AI animals
displayed increased synaptosome RARa content relative to
Y and AU rats (F(2,17) = 6.561, p=0.008; Y vs AI p=0.026,
AU vs AI p=0.014; Fig. 5F), also similar to the pattern in
whole lysates. Additionally, synaptosome RA receptor ex-
pression positively correlated with spatial memory per-
formance among the Y and aged rats, with higher LI scores
(i.e., poor memory) associated with increased RARa pro-
tein expression (n=20, r2 = 0.312, p=0.011; Fig. 5G, gray
line). A similar positive correlation was also observed when
the aged animals were considered alone in the analysis
(n=15, r2 = 0.314, p=0.030; Fig. 5G, black line). These re-
sults indicate that RARa expression is increased selectively
in aged animals with memory impairment in both whole cell
and synaptosome preparations. Among the aged rats,
levels of this receptor localized to the synaptosome com-
partment were coupled with individual differences in hippo-
campal memory.
Hippocampal FMRP protein is increased in aged
animals
Next, we examined FMRP protein expression, which is
required for the translation of GluR1 mRNA. We found sig-
nificantly increased levels of FMRP protein in the aged
hippocampus (t(22) = 3.27, p=0.0035; Fig. 6B). AI values
were elevated relative to Y rats (F(2,21) = 7.202, p=0.004;
Y vs AI p=0.003; Fig. 6C), whereas results for AU were in-
termediate and failed to differ from either Y or AI (Fig. 6C).
FMRP protein levels failed to correlate with LI scores, and
overall, the data point to a general age-related increase in
hippocampal FMRP.
Cellular and synaptosome GluR1 levels are increased
in aged animals with memory impairment
In the presence of FMRP, GluR1 mRNA is translated lo-
cally in a RARa regulated manner, enhancing AMPA re-
ceptor synaptic expression and strength. We measured
GluR1 receptor protein levels in whole cell lysates and as-
sociated synaptosome preparations. No differences
were observed in GluR1 expression between the Y and
aged group (t(22) = 0.776, p=0.446; Fig. 6D). However,
GluR1 protein was significantly increased in AI animals
compared with AU (F(2,21) = 4.161, p=0.030, AU vs AI
p=0.031; Fig. 6E), although neither aged subgroup dif-
fered from Y. The correlation between GluR1 protein lev-
els and spatial memory was not significant when the Y
and aged animals were considered together (n=24, r2 =
0.061, p=0.245 Fig. 6F, gray line). However, a reliable corre-
lation was observed among the aged animals (n=16, r2 =
0.248, p=0.050; Fig. 6F, black line), where poor spatial mem-
ory (i.e., high LI scores) was associated with higher hippo-
campal GluR1 levels.
In the synaptosome fraction, we found higher GluR1
protein expression in the aged rats than Y (t(18) = 3.104,
p=0.006; Fig. 6G), and this effect appeared largely attrib-
utable to elevation among AI animals (F(2,17) = 5.865,
p=0.012; Y vs AI p=0.009; Fig. 6H). Although we found
no direct correlation between spatial memory perform-
ance and synaptosome GluR1 levels, the results suggest
that ionotropic glutamate expression in hippocampus, in
both the cytosol and synaptosome, is predominantly in-
creased in AI rats.
Discussion
Research on the neurobiology of cognitive aging has
traditionally focused on identifying differences between
groups configured on the basis of chronological age. This
approach, however, can obscure the increased individual
variability that is a hallmark of aging in humans and animal
models. Here, adopting a strategy validated in many pre-
vious studies (McQuail et al., 2018; Rapp et al., 1987,
2020), we explicitly capitalized on this variability to test
whether changes in RA signaling are associated with dif-
ferential cognitive outcomes in aging. The current evi-
dence clearly documents that RA signaling in the
hippocampus is disrupted across multiple levels of regu-
lation in aged rats with memory deficits. Specifically,
while levels of a key transporter of the substrate for RA
(STRA6) were decreased in the aged hippocampus inde-
pendent of cognitive status, changes in other compo-
nents of the RA signaling pathway, including but not
limited to synthesis and catabolism of RA (RALDH1,
CYP26B1, RARa, FMRP, and GluR1), were selectively in-
creased among aged animals with memory impairment.
Levels of most of the affected RA signaling factors were
reliably correlated with individual differences in spatial
memory among aged rats. Although the specific mecha-
nisms linking changes in RA signaling to disrupted memo-
ry-related plasticity remain to be determined, in the
aggregate our results point to an overall increase in hippo-
campal RA signaling associated with age-related cogni-
tive impairment. While previous studies have suggested
that global RA decline leads to cognitive impairment
(Etchamendy et al., 2001; Bonnet et al., 2008; Dumetz et
al., 2020), our findings suggest that locally increased RA
signaling is coupled with age-related cognitive decline,
perhaps reflecting failed compensatory mechanisms.
Alongside experimental design factors that might contrib-
ute to apparent discrepancies across studies, such as rat
strain and diet, the current results highlight the impor-
tance of considering RA signaling in relation to individual
variability in the cognitive outcome of aging. Nonetheless,
a priority knowledge gap for future investigation is to ex-
plore the direction of causality, testing whether the ob-
served effects of aging on RA signaling are a driver of, or
response to, cognitive decline.
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Figure 6. FMRP expression and cellular and dendritic expression of GluR1 in the hippocampus. Representative blots for proteins of
interest (A), FMRP expression relative to GAPDH (bottom four panels); cellular GluR1 expression relative to b -actin, and synapto-
some GluR1 levels relative to PSD95 (top two panels); L stands for molecular ladder lane. Cytosolic fraction included as confirma-
tion of the fractionation. Hippocampal expression of FMRP (B, C). Whole hippocampus (D, E) and synaptosome GluR1 protein
levels (G, H). Correlation of cytosolic GluR1 protein expression with LI scores (F). Results shown as bars with individual animal data
plotted. Statistical analysis, unpaired two-tailed Student’s t test (B, D, G), one-way ANOVA, with Tukey’s multiple comparisons test
(C, E, H), and linear regression (F; all animals, gray line; aged animals, black line); C, cytosolic fraction; **p, 0.01. Y n=8 and aged
n=16 (AU n=8, AI n=8; B–F); Y n=5 and aged n=15 (AU n=7, AI n=8; G, H). Error bars represent SEM.
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Retinol availability in aged animals
The availability of retinol in the circulation is essential
for the synthesis of RA. Circulating levels of retinol are de-
pendent on dietary availability of vitamin A and are influ-
enced by retinol storage in the liver, which is the largest
storage site in the body (Napoli, 2012). The major pathway
for retinol transport is through binding to RBP4/TTR com-
plex (Li et al., 2014), and here, we used plasma RBP4 lev-
els as a proxy for retinol content in the circulation.
Animals in this study were maintained under identical
conditions, ensuring that dietary retinol availability was
constant and not the basis of the RBP4 differences seen
between the aged groups.
Our results revealed significantly lower RBP4 plasma
levels in AU animals compared with Y. This is consistent
with recent findings in humans showing decreased plas-
ma RBP4 content in aged individuals (Soo Lee et al.,
2013; Kocełak et al., 2018). Interestingly, AI animals had
RBP4 levels comparable to Y and significantly higher
than AU rats. The liver and kidney prominently influence
RBP4, because of their role in synthesis and excretion,
respectively. Plasma triglyceride levels, which are indica-
tive of liver function, were comparable across groups,
suggesting that impaired liver function is unlikely to
drive changes in RBP4. Renal function also affects cir-
culating RBP4 and can be assessed by plasma creati-
nine levels, where high levels are indicative of kidney
disease. Kocełak et al. (2018) found increased circulat-
ing RBP4 in patients with chronic kidney disease. That
study concluded that plasma levels of this RBP pre-
dominantly reflect poor kidney function and are only
modestly sensitive to aging. Here, we found no age-re-
lated change in this binding protein. Overall, plasma
RBP4 in aged animals strongly correlated with LI
scores, where low levels were detected in AU plasma.
Together, this pattern of results raises the possibility
that the selective decrease of plasma RBP4 seen in AU
rats may be a component of an adaptive cascade, re-
ducing retinol availability in blood, and providing a po-
tential biomarker of resilient cognitive aging.
Some studies have reported an increase in RBP4
with obesity and insulin resistance (Esteve et al., 2009;
Shajarian et al., 2015), whereas others have found no
relationship (Ûlgen et al., 2010; Kocełak et al., 2018).
Aged rats in the present experiment did not display
visible signs indicative of disrupted glucose regulation
(e.g., increased water consumption and urination, or
sharp weight gain), confirmed by normative circulating
glucose levels. Additionally, plasma triglyceride con-
tent, a core component of the metabolic syndrome,
was similar between groups. Creatinine levels further
suggested that the rats were free of underlying renal
disease that might influence RBP4 levels. Although the
aged animals were significantly heavier and exhibited
greater adiposity than Y, RBP4 levels were unrelated
to body weight. Therefore, differences in plasma RBP4
among the aged rats were not secondary to weight
gain or systemic metabolism change, and instead
point to a potential RA influence on cognitive aging in-
dependent of metabolic aging.
Global increase of RAmetabolism in AI animals
A significant role of RA in memory is emerging, comple-
menting reports that, in the hippocampus, RA is involved
in homeostatic synaptic scaling (Aoto et al., 2008; Sarti et
al., 2012; Hsu et al., 2019). Although there is evidence
that retinol signaling is altered in the aged brain (Enderlin
et al., 1997; Touyarot et al., 2013), the involvement of RA
in cognitive aging has received limited attention.
Our findings establish that protein levels of STRA6 re-
ceptor, which plays an important role in the retinol trans-
port across blood-tissue barriers (Kelly et al., 2016), are
decreased in the aged hippocampus. In brain, expression
of this receptor is regulated by the availability of vitamin
A, and in tissues other than the eye, cytosolic retinol con-
centration is only partly regulated by STRA6 (Berry et al.,
2013). In our model, age-related decline in hippocampal
STRA6 expression does not appear to be a consequence
of systemic change in retinol, as the results fail to parallel
the observed changes in plasma RBP4 levels. Regardless
of the mechanism, which remains to be determined, the
reduction in STRA6 may reduce intracellular retinol avail-
ability. This is consistent with decreased retinoid brain
levels in aged mice (Kelly et al., 2016).
We also examined the abundance of RA synthesizing
and catabolizing enzymes in the hippocampus. Retinal
dehydrogenase enzymes are responsible for the last
step of RA synthesis. In the present experiments, RALDH1
expression was increased in aged animals, whereas
RALDH3 levels were unchanged. Increased RALDH1 levels
in the aged hippocampus contrast with reports of reduced
retinol metabolism in other tissues (Etchamendy et al.,
2003; Van Der Loo et al., 2004; Das et al., 2014) raising the
possibility that the increase is a brain-specific response
in aging. In the future it will be useful to extend the anal-
ysis to include the third RA synthesizing enzyme,
RALDH2. The RA catabolic enzymes CYP26A1 and
CYP26B1 are both expressed in the rat hippocampus
(McCaffery and Simons, 2007; Stoney et al., 2016).
CYP26A1 has greater catalytic activity for RA than
CYP26B1 (Topletz et al., 2012), although CYP26B1 is
more widely distributed in the brain (Stoney et al., 2016)
and tightly regulates RA signaling during development
(Abu-Abed et al., 2002). CYP26 gene expression is dy-
namically regulated by dietary retinol and RA from liver
and extrahepatic tissues (Ray et al., 1997; Wang et al.,
2002) While liver CYP26B1 is reportedly upregulated in
aged subjects (Yamamoto et al., 2000), whether brain
expression changes with age is unknown. Here, we
found no difference in CYP26A1 between Y and aged
animals, whereas CYP26B1 protein levels increased
with age. In line with the observed increase in synthe-
sizing enzyme, the predicted consequence of enhanced
RA presence is a net increase in CYP26B1-mediated
catabolism.
One of the non-genomic functions of RA is mediated by
RARa, which undergoes active nuclear transport (Poon
and Chen, 2008). This receptor is implicated in homeo-
static synaptic scaling (Chen et al., 2014; Li et al., 2019),
synaptic transmission in somatosensory cortex (Yee and
Chen, 2016), and normal tactile sensory processing (Park
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et al., 2018). Here, we found significantly higher levels of
RARa in AI rats, in both cytosolic and synaptosome frac-
tions from hippocampus, suggesting that non-genomic
RA action is affected in these animals. The presumed con-
sequence is greater RARa availability for RA to bind to
and release GluR1 mRNA, increasing availability for
translation.
The translation of GluR1 mRNA critically depends on
FMRP. This protein is not directly related to the RA signal-
ing pathway, but it is an important mediator of RA’s down-
stream effects. An RNA-binding functional regulator,
FMRP localizes to cytosolic membranes and the nucleus
(Bostrom et al., 2016; Smidak et al., 2017), where it con-
trols synaptic protein synthesis, modulating dendritic
spine formation (Feng et al., 1997; Greenough et al., 2001;
Weiler et al., 2004). Deficiency of FMRP leads to local pro-
tein synthesis-dependent endocytosis of GluR1 receptor
(Nakamoto et al., 2007), and activation of GluRs influen-
ces dendritic FMRP localization (Antar, 2004). In contrast
to previous reports (Singh et al., 2007; Smidak et al.,
2017), our findings demonstrate modest but statistically
reliable increases in hippocampal FMRP protein in aged
rats, an effect predominantly attributable to AI rats. This
increase, together with higher expression of GluR1, is
positioned to potently influence excitatory neurotransmis-
sion in the hippocampus. Interestingly, pyramidal neurons
in the hippocampal CA3 region of AI animals exhibit ele-
vated firing rates (Wilson et al., 2005), and pharmacologi-
cal treatments that reduce hyperactivity improve memory
in both AI rats and MCI patients (Koh et al., 2010; Bakker
et al., 2012). RA actions via RARa are also known to
cause downscaling of synaptic inhibition by FMRP-de-
pendent removal of synaptic GABAA receptors (Sarti et
al., 2013). It is possible, that altered GluR1 expression
and network disinhibition lead to disrupted excitation/in-
hibition balance, which in turn may contribute to memory
impairments observed in aged rats.
In conclusion, compelling evidence indicates that RA
function extends well beyond metabolic control and in-
cludes regulation of memory-related synaptic plasticity.
Here, we demonstrate that RA signaling in neurocogni-
tive aging is affected at nearly all levels of regulation ex-
amined. We found a decrease in plasma RBP4 in aged
animals without memory impairment. Net hippocampal
RA signaling is likely increased in aged rats with cogni-
tive impairment, reflecting in part greater synthesizing
and catabolizing enzyme expression. Furthermore, we
find increases in RARa, FMRP and GluR1 selectively in
aged rats with memory impairments. These changes
appear unrelated to metabolic aging, and instead most
are specifically related to individual differences in the
cognitive outcome of aging rather than chronological
age. The importance of neuronal excitation/inhibition
balance in relation to cognitive outcome has been high-
lighted in many studies and is the core of numerous
neurologic diseases where altered RA signaling is impli-
cated (Wołoszynowska-Fraser et al., 2020). Together,
the current results lean in favor of increased RA signal-
ing, potentially contributing to the excitation/inhibition
imbalance that is prominently featured in age-related
cognitive impairment. This work further extends the
boundaries of RA function in brain, and specifically
highlights the importance of considering aging effects
in relation to individual variability in cognitive aging.
Among potential future directions, a comprehensive ac-
count of RA signaling influences on neurocognitive
aging will also require a parallel assessment of genomic
pathway effects.
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